Investigation identifies genomic mechanisms influencing factor V levels in mice megakaryocytes and hepatocytes, suggesting further studies.
Background Factor V (FV) plays a central role in the coagulation cascade, acting in both a procoagulant and anticoagulant manner. The majority of FV is produced by the liver hepatocytes. In humans, FV is endocytosed by megakaryocytes, whereas in mice, FV is synthesized by megakaryocytes. Little is known about the genomic factors regulating FV transcription in humans and mice. Objective To investigate genomic regulatory mechanisms for coagulation FV levels in the hepatocytes and megakaryocytes of inbred mice. Methods Plasma and platelet FV levels were measured via ELISA in 5 mouse strains. A cross between the CAST/EiJ and DBA/2J strains was performed to generate 146 genetically informative F2 mice for analysis of circulating and platelet FV. Plasma and platelet FV levels were measured by ELISA for the F2 mice and whole genome genotyping for each F2 was performed using the TransnetYX MiniMUGA genotyping array. The genotyping and phenotyping data collected from these mice were then analyzed using quantitative trait loci (QTL) analysis. Results and Conclusions We identified one significant locus controlling plasma FV levels on Chromosome 1, ~57.7 million base pairs upstream of the FV structural gene. We also identified a significant QTL for platelets on Chromosome 14 when sex was included as an interactive covariate, with additional suggestive loci present on Chromosomes 15 and 2. Our findings provide foundational information regarding the cell-type and sex-specific control of FV expression, establishing the basis for further investigations aimed at fine-mapping these loci and understanding how FV expression is regulated.
No takes yet. Share an insight, caveat, or question.
Jurek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: